Results 161 to 170 of about 729,991 (222)

CircRNA based bi-antigen vaccines against mpox virus induce potent and durable cross-protection in mice. [PDF]

Mol Biomed
Zhou J, Wang C, Wu Y, Zhao B, Yang Y, Ye T, Zhang K, Li F, Hu J, Zhang K, Liu F, Wang W, Wang C, Wang Z, Chuai X, Chiu S.   +15 more
europepmc   +1 more source

A potent Gc neutralizing antibody reveals architecture-dependent bispecific protection against SFTSV. [PDF]

Emerg Microbes Infect
Lu H, Li L, Zhang N, Liu Y, Liu B, Sun Y, Zhang J, Liu S, Luo J, Liao J, Lv K, Yue X, Xu M, Zhao J, Wu X, Chen X, Tao C, Guo Y, Zhang Z, Wang M, Chen YQ.   +20 more
europepmc   +1 more source

Early intervention, lasting impact: benefits of early antiretroviral therapy and implications for posttreatment control. [PDF]

Curr Opin HIV AIDS
Bolluyt DC, de Bree GJ, Pasternak AO.
europepmc   +1 more source

Low effectiveness of influenza vaccines vis-à-vis mechanism of protection by vaccines - potential causes and recommendations to improve control of influenza. [PDF]

Front Immunol
Gupta RK, Alugupalli KR, Cowell JL.
europepmc   +1 more source

The Shifting Core: Antigenic Variability of the Influenza Virus Nucleoprotein Despite Evolutionary Conservation. [PDF]

Antibodies (Basel)
Rak A, Muzurova V, Donina S, Prokopenko P, Isakova-Sivak I, Rudenko L.   +5 more
europepmc   +1 more source

Interactions between the 2C protein of foot-and-mouth disease virus and components of the viral replication machinery are mediated by endoplasmic reticulum-derived membranes. [PDF]

J Gen Virol
Hayward C, Hietanen EV, Dobson SJ, Bishop R, Herod MR, Fontana J, Rowlands DJ, Stonehouse NJ.   +7 more
europepmc   +1 more source